
|Articles|October 3, 2008
Anika Therapeutics announces Canadian distribution agreement for Elevess
Bedford, Mass. - Anika Therapeutics has signed an agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.
Advertisement
Bedford, Mass.
- Anika Therapeutics has signed an exclusive agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.
Elevess is the first hyaluronic acid filler with lidocaine to be approved by the U.S. Food and Drug Administration.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians See Intersection of Weight Loss and Facial Aging
2
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
3
The “6-7” Advances for Dermatologists to Look Forward to in 2026
4
Q&A: Saami Khalifian, MD, FAAD, on Integrating BOTOX Cosmetic into Lower Face and Neck Rejuvenation
5


















